CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 85 filers reported holding ENZO BIOCHEM INC in Q4 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$18,859
-23.9%
13,4710.0%0.00%
Q2 2023$24,787
-24.3%
13,4710.0%0.00%
Q1 2023$32,735
+69.9%
13,4710.0%0.00%
Q4 2022$19,264
-37.9%
13,4710.0%0.00%
Q3 2022$31,000
+10.7%
13,4710.0%0.00%
Q2 2022$28,000
-30.0%
13,4710.0%0.00%
Q1 2022$40,000
-9.1%
13,4710.0%0.00%
Q4 2021$44,000
-8.3%
13,4710.0%0.00%
Q3 2021$48,000
+11.6%
13,4710.0%0.00%
Q2 2021$43,000
-88.2%
13,471
-87.3%
0.00%
Q1 2021$365,000
+36.2%
106,0090.0%0.00%
Q4 2020$268,000
+19.6%
106,0090.0%0.00%
Q3 2020$224,000
-62.1%
106,009
-59.8%
0.00%
Q2 2020$591,000
-5.9%
263,822
+6.4%
0.00%
Q1 2020$628,000
-2.5%
248,066
+1.4%
0.00%
Q4 2019$644,000
-26.1%
244,603
+1.1%
0.00%
-100.0%
Q3 2019$871,000
+1.5%
241,924
-4.9%
0.00%0.0%
Q2 2019$858,000
+35.3%
254,331
+9.5%
0.00%
Q1 2019$634,000
-2.3%
232,175
-0.4%
0.00%
Q4 2018$649,000
-33.4%
233,173
-1.3%
0.00%
-100.0%
Q3 2018$974,000
-15.5%
236,361
+6.5%
0.00%0.0%
Q2 2018$1,152,000
-2.2%
221,890
+3.3%
0.00%0.0%
Q1 2018$1,178,000
-18.8%
214,867
+20.8%
0.00%0.0%
Q4 2017$1,450,000
-30.9%
177,896
-11.3%
0.00%
-50.0%
Q3 2017$2,099,000
+51.7%
200,450
+60.0%
0.00%
+100.0%
Q2 2017$1,384,000
+57.3%
125,281
+19.2%
0.00%0.0%
Q1 2017$880,000
+20.5%
105,0810.0%0.00%0.0%
Q4 2016$730,000
+36.4%
105,0810.0%0.00%0.0%
Q3 2016$535,000
-14.8%
105,0810.0%0.00%0.0%
Q2 2016$628,000
+212.4%
105,081
+138.9%
0.00%
Q1 2016$201,000
+1.5%
43,9810.0%0.00%
Q4 2015$198,000
+41.4%
43,9810.0%0.00%
Q3 2015$140,000
+4.5%
43,9810.0%0.00%
Q2 2015$134,000
-51.8%
43,981
-53.3%
0.00%
Q1 2015$278,000
-39.2%
94,081
-8.4%
0.00%
-100.0%
Q4 2014$457,000
-35.0%
102,718
-24.7%
0.00%0.0%
Q3 2014$703,000
-2.0%
136,3910.0%0.00%0.0%
Q2 2014$717,000
+59.0%
136,391
+25.9%
0.00%0.0%
Q1 2014$451,000
+108.8%
108,341
+47.1%
0.00%
Q4 2013$216,000
+16.8%
73,6410.0%0.00%
Q3 2013$185,000
+10.1%
73,641
-6.5%
0.00%
Q2 2013$168,00078,7810.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2020
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,392,642$6,939,00011.21%
VIEX Capital Advisors, LLC 1,435,130$4,162,0007.44%
HARBERT FUND ADVISORS, INC. 5,175,913$15,010,0006.29%
Potomac Capital Management, Inc. 496,805$1,441,0001.24%
AMH Equity Ltd 30,000$87,0000.09%
Corsair Capital Management 75,026$218,0000.05%
RBF Capital, LLC 250,359$730,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$74,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 539,954$1,566,0000.04%
Cutter & CO Brokerage, Inc. 25,777$75,0000.02%
View complete list of ENZO BIOCHEM INC shareholders